| scholarly article | Q13442814 |
| P2093 | author name string | Helena Edlund | |
| Jacob Westman | |||
| Ingela Bergqvist | |||
| Fredrik Backlund | |||
| Pär Steneberg | |||
| Thomas Edlund | |||
| Madelene Ericsson | |||
| Emma Lindahl | |||
| Ulf Dahl | |||
| Björn Eriksson | |||
| Elisabet Kjellkvist | |||
| Emmelie Lidh | |||
| Eva Berggren | |||
| Ingela Lundberg | |||
| Jurate Straseviciene | |||
| Kajsa Linde | |||
| P2860 | cites work | AMPK and PPARdelta agonists are exercise mimetics | Q24652674 |
| Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy | Q26775037 | ||
| Autophagy fights disease through cellular self-digestion | Q27860902 | ||
| Glucose deprivation regulates KATP channel trafficking via AMP-activated protein kinase in pancreatic beta-cells | Q28566857 | ||
| Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle | Q30397046 | ||
| Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo | Q30618321 | ||
| TXNIP regulates peripheral glucose metabolism in humans | Q33283341 | ||
| Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity | Q33944212 | ||
| Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes | Q33944267 | ||
| Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia. | Q34115152 | ||
| Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. | Q34191173 | ||
| Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose | Q34204855 | ||
| Arginine is preferred to glucagon for stimulation testing of β-cell function | Q34356000 | ||
| Islet beta cell failure in type 2 diabetes | Q34698810 | ||
| AMPK in cardiovascular health and disease | Q34807222 | ||
| Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people | Q35004093 | ||
| Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions | Q35092842 | ||
| AMP-activated protein kinase and muscle glucose uptake | Q35178589 | ||
| Multiparametric assessment of vascular function in peripheral artery disease: dynamic measurement of skeletal muscle perfusion, blood-oxygen-level dependent signal, and venous oxygen saturation | Q35439029 | ||
| The unfolded protein response--a stress signaling pathway of the endoplasmic reticulum | Q35885345 | ||
| Pancreatic β-Cell Dysfunction in Diet-Induced Obese Mice: Roles of AMP-Kinase, Protein Kinase Cε, Mitochondrial and Cholesterol Metabolism, and Alterations in Gene Expression | Q35979184 | ||
| The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice. | Q36038197 | ||
| GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial | Q36113842 | ||
| Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults | Q36392864 | ||
| The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux | Q36430696 | ||
| Expression and transcriptional profiling of the LKB1 tumor suppressor in cervical cancer cells | Q36459906 | ||
| Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance | Q36459921 | ||
| The Human Microcirculation: Regulation of Flow and Beyond | Q36547176 | ||
| AMPK and Exercise: Glucose Uptake and Insulin Sensitivity. | Q36628896 | ||
| AMPK, insulin resistance, and the metabolic syndrome | Q36966839 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure | Q37412140 | ||
| Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. | Q37545950 | ||
| Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function. | Q37588539 | ||
| Skeletal muscle insulin resistance is the primary defect in type 2 diabetes | Q37624257 | ||
| Fighting disease by selective autophagy of aggregate-prone proteins | Q37735987 | ||
| Islet amyloid polypeptide, islet amyloid, and diabetes mellitus | Q37899668 | ||
| AMP-activated protein kinase: also regulated by ADP? | Q37904132 | ||
| Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. | Q38399909 | ||
| Regulation of brown fat by AMP-activated protein kinase | Q38566113 | ||
| Future glucose-lowering drugs for type 2 diabetes. | Q38711383 | ||
| Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest? | Q38744831 | ||
| Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes. | Q38762377 | ||
| Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice | Q38799483 | ||
| Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy | Q38974302 | ||
| Exercise, fasting, and mimetics: toward beneficial combinations? | Q38978278 | ||
| Pathophysiology of Intermittent Claudication in Peripheral Artery Disease | Q39103498 | ||
| AMPK regulates ER morphology and function in stressed pancreatic β-cells via phosphorylation of DRP1. | Q39104609 | ||
| AMPK modulates glucose-sensing in insulin-secreting cells by altered phosphotransfer to KATP channels | Q39168370 | ||
| Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice | Q39308812 | ||
| AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System. | Q39331294 | ||
| AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. | Q39542812 | ||
| Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy | Q40633453 | ||
| The mechanisms of action of metformin | Q41353984 | ||
| AMPK Phosphorylates Desnutrin/ATGL and Hormone-Sensitive Lipase To Regulate Lipolysis and Fatty Acid Oxidation within Adipose Tissue | Q42429527 | ||
| Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia | Q42442810 | ||
| Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet | Q42442818 | ||
| Exercise training before cardiac-specific Serca2 disruption attenuates the decline in cardiac function in mice | Q42877943 | ||
| Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion | Q43132682 | ||
| Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise | Q44448758 | ||
| Moderate exercise restores pancreatic beta-cell function and autonomic nervous system activity in obese rats induced by high-fat diet | Q46429085 | ||
| Cold-Induced Thermogenesis Depends on ATGL-Mediated Lipolysis in Cardiac Muscle, but Not Brown Adipose Tissue. | Q47141278 | ||
| Lipolysis in Brown Adipocytes Is Not Essential for Cold-Induced Thermogenesis in Mice. | Q47842456 | ||
| mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells | Q49589205 | ||
| Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. | Q51022456 | ||
| Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve. | Q51327644 | ||
| Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. | Q52675077 | ||
| AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats. | Q54531929 | ||
| Intensity and duration effects of exercise on heart cAMP, phosphorylase, and glycogen | Q70137796 | ||
| Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging | Q78555985 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P577 | publication date | 2018-06-21 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients | |
| P478 | volume | 3 |
| Q92342120 | AMP-activated protein kinase: the current landscape for drug development |
| Q61451626 | Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD |
| Q91386361 | New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery |
| Q99551357 | Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue |
| Q99560905 | Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake |
| Q59793666 | Structure and Physiological Regulation of AMPK |
| Q90242473 | Targeting metabolic dysregulation for fibrosis therapy |
Search more.